» Articles » PMID: 34065122

Excessive Iron Induces Oxidative Stress Promoting Cellular Perturbations and Insulin Secretory Dysfunction in MIN6 Beta Cells

Overview
Journal Cells
Publisher MDPI
Date 2021 Jun 2
PMID 34065122
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Exposure to high levels of glucose and iron are co-related to reactive oxygen species (ROS) generation and dysregulation of insulin synthesis and secretion, although the precise mechanisms are not well clarified. The focus of this study was to examine the consequences of exposure to high iron levels on MIN6 β-cells. MIN6 pseudoislets were exposed to 20 µM (control) or 100 µM (high) iron at predefined glucose levels (5.5 mM and 11 mM) at various time points (3, 24, 48, and 72 h). Total iron content was estimated by a colourimetric FerroZine™ assay in presence or absence of transferrin-bound iron. Cell viability was assessed by a resazurin dye-based assay, and ROS-mediated cellular oxidative stress was assessed by estimating malondialdehyde levels. β-cell iron absorption was determined by a ferritin immunoassay. Cellular insulin release and content was measured by an insulin immunoassay. Expression of SNAP-25, a key protein in the core SNARE complex that modulates vesicle exocytosis, was measured by immunoblotting. Our results demonstrate that exposure to high iron levels resulted in a 15-fold (48 h) and 4-fold (72 h) increase in cellular iron accumulation. These observations were consistent with data from oxidative stress analysis which demonstrated 2.7-fold higher levels of lipid peroxidation. Furthermore, exposure to supraphysiological (11 mM) levels of glucose and high iron (100 µM) at 72 h exerted the most detrimental effect on the MIN6 β-cell viability. The effect of high iron exposure on total cellular iron content was identical in the presence or absence of transferrin. High iron exposure (100 µM) resulted in a decrease of MIN6 insulin secretion (64% reduction) as well as cellular insulin content (10% reduction). Finally, a significant reduction in MIN6 β-cell SNAP-25 protein expression was evident at 48 h upon exposure to 100 µM iron. Our data suggest that exposure to high iron and glucose concentrations results in cellular oxidative damage and may initiate insulin secretory dysfunction in pancreatic β-cells by modulation of the exocytotic machinery.

Citing Articles

Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus.

Dai L, Wang Q Stem Cell Res Ther. 2025; 16(1):47.

PMID: 39901210 PMC: 11792594. DOI: 10.1186/s13287-025-04188-7.


RISING STARS: Evidence for established and emerging forms of β-cell death.

Colglazier K, Mukherjee N, Contreras C, Templin A J Endocrinol. 2024; 262(2).

PMID: 38842911 PMC: 11285760. DOI: 10.1530/JOE-23-0378.


Antioxidant and Antidiabetic Properties of a Thinned-Nectarine-Based Nanoformulation in a Pancreatic β-Cell Line.

Schiano E, Novellino E, Gamez Fernandez M, Tiekou Lorinczova H, Tenore G, Iannuzzo F Antioxidants (Basel). 2024; 13(1).

PMID: 38247487 PMC: 10812739. DOI: 10.3390/antiox13010063.


The Link between Trace Metal Elements and Glucose Metabolism: Evidence from Zinc, Copper, Iron, and Manganese-Mediated Metabolic Regulation.

Sun Z, Shao Y, Yan K, Yao T, Liu L, Sun F Metabolites. 2023; 13(10).

PMID: 37887373 PMC: 10608713. DOI: 10.3390/metabo13101048.


Ferritin and iron supplements in gestational diabetes mellitus: less or more?.

Li T, Zhang J, Li P Eur J Nutr. 2023; 63(1):67-78.

PMID: 37775606 DOI: 10.1007/s00394-023-03250-5.


References
1.
Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

2.
Halliwell B . The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis. 1993; 23 Suppl 1:118-26. DOI: 10.1159/000216921. View

3.
Kautzky-Willer A, Harreiter J, Pacini G . Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016; 37(3):278-316. PMC: 4890267. DOI: 10.1210/er.2015-1137. View

4.
Paul B, Manz D, Torti F, Torti S . Mitochondria and Iron: current questions. Expert Rev Hematol. 2016; 10(1):65-79. PMC: 5538026. DOI: 10.1080/17474086.2016.1268047. View

5.
Johnson D, Shepherd R, Gill D, Gorman T, Smith D, Dunne M . Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. Diabetes. 2007; 56(6):1694-702. DOI: 10.2337/db07-0026. View